Global Ibuprofen Injection Market Insights and Forecast to 2028

SKU ID :QYR-19941635 | Published Date: 10-Jan-2022 | No. of pages: 109
Market Analysis and Insights: Global Ibuprofen Injection Market
Due to the COVID-19 pandemic, the global Ibuprofen Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 4ml:0.4g accounting for % of the Ibuprofen Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Ibuprofen Injection market size is valued at US$ million in 2021, while the US and Europe Ibuprofen Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ibuprofen Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Ibuprofen Injection include Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc., Alveda Pharmaceuticals (Teligent), Soho Industri Pharmasi, Grifols, Easton Biopharmaceuticals, Sihuan Pharmaceutical and Chengdu Brilliant Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ibuprofen Injection Scope and Segment
Ibuprofen Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ibuprofen Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
4ml:0.4g
8ml:0.8g
Segment by Application
Hospitals
Clinics
Others
By Company
Cumberland Pharmaceuticals
CSL Limited
Akorn, Inc.
Alveda Pharmaceuticals (Teligent)
Soho Industri Pharmasi
Grifols
Easton Biopharmaceuticals
Sihuan Pharmaceutical
Chengdu Brilliant Pharmaceutical
Minsheng Pharmaceutical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
  • PRICE
  • $4900
    $9800
    $7350
    Buy Now

Our Clients